PBJ ETF's small/mid-cap exposure, high expense ratio, and challenges from inflation and GLP-1 adoption make it a 'Sell'. Find ...

Are you looking for the complete & verified bond data? — We have everything you need: full data on over 900 000 bonds, 80 000 stocks, 116 000 ETF & Funds; powerful bond screener; over 350 pricing ...

Psychedelics litigator Matthew Zorn joins HHS under RFK Jr. to lead policy. What it means for CMPS, MNMD, CYBN, PSIL & more.

The U.S. Department of Health and Human Services said on Tuesday it would set drug prices pegged to the lowest level paid by ...

HHS unveiled the first details Tuesday on plans to tie U.S. drug prices to an international index, a so-called Most Favored ...

These exchange-traded funds won't even need constant monitoring. In fact, you'd be better served in the long run by not ...

The proposal is expected to face strong pushback once again from drug manufacturers (read: A Look at Pharma ETFs After Strong Q1 Earnings). This policy has immediate implications for the ...

The first-quarter results of the healthcare sector have been impressive, with earnings of 85% of the sector participants that have reported so far up 46.8% on 8% revenue growth. The earnings beat ...

Betashares Global Healthcare Ccy Hdg ETF has an average Morningstar Sustainability Rating of 3 globes, indicating that the ESG risk of holdings in its portfolio is similar to that of its peers in ...

E Fund CSI Brand Name Drug Industry ETF has an average Morningstar Sustainability Rating of 3 globes, indicating that the ESG risk of holdings in its portfolio is similar to that of its peers in ...

This ETF tracks the CRSP US Large Cap Growth Index ... precision medicine, and drug development technologies. The fund's exposure to leading healthcare and life sciences companies offers investors ...

The VPU ETF has a 3% yield and has jumped by 3.5% this year. The healthcare sector will always be a good defensive area to park your money because of the rising demand of drugs. Also, most people ...